Suchergebnisse - Dianping Yu

Cordycepin Targets HRD1 to Promote Cancer Cell PD‐L1 Ubiquitin–Proteasome Degradation and Increase Antitumor Immunity von Xiangxin Geng, Minchen Cai, Hongmei Hu, Mengting Xu, Qing Zhang, Hanchen Xu, Dianping Yu, Hongwei Zhang, Hanchi Xu, Linyang Li, Mengmeng Guo, Shize Xie, Qun Wang, Weidong Zhang, Sanhong Liu

Volltext

Network Medicine‐Based Strategy Identifies Maprotiline as a Repurposable Drug by Inhibiting PD‐L1 Expression via Targeting SPOP in Cancer von Saisai Tian, Mengting Xu, Xiangxin Geng, Jiansong Fang, Hanchen Xu, Xinying Xue, Hongmei Hu, Qing Zhang, Dianping Yu, Mengmeng Guo, Hongwei Zhang, Jinyuan Lu, Chengyang Guo, Qun Wang, Sanhong Liu, Weidong Zhang

Volltext

5,7,4′‐Trimethoxyflavone triggers cancer cell PD‐L1 ubiquitin–proteasome degradation and facilitates antitumor immunity by targeting HRD1 von Jianhua Xia, Mengting Xu, Hongmei Hu, Qing Zhang, Dianping Yu, Minchen Cai, Xiangxin Geng, Hongwei Zhang, Yanyan Zhang, Mengmeng Guo, Dong Lu, Hanchi Xu, Linyang Li, Xing Zhang, Qun Wang, Sanhong Liu, Weidong Zhang

Volltext

Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual‐Targeting BMI1 for Senescence Induction and CSN5 for PD‐L1 Degradation von Hongmei Hu, Qun Wang, Dianping Yu, Xiaoyu Tao, Mengmeng Guo, Saisai Tian, Qing Zhang, Mengting Xu, Xiangxin Geng, Hongwei Zhang, Hanchi Xu, Linyang Li, Shize Xie, Kaixian Chen, Weiliang Zhu, Xu‐Wen Li, Hanchen Xu, Bo Li, Weidong Zhang, Sanhong Liu

Volltext

Berberine Derivative B68 Promotes Tumor Immune Clearance by Dual‐Targeting BMI1 for Senescence Induction and CSN5 for PD‐L1 Degradation (Adv. Sci. 7/2025) von Hongmei Hu, Qun Wang, Dianping Yu, Xiaoyu Tao, Mengmeng Guo, Saisai Tian, Qing Zhang, Mengting Xu, Xiangxin Geng, Hongwei Zhang, Hanchi Xu, Linyang Li, Shize Xie, Kaixian Chen, Weiliang Zhu, Xu‐Wen Li, Hanchen Xu, Bo Li, Weidong Zhang, Sanhong Liu

Volltext